184 related articles for article (PubMed ID: 15659880)
1. Challenges for HIV vaccine dissemination and clinical trial recruitment: if we build it, will they come?
Newman PA; Duan N; Rudy ET; Anton PA
AIDS Patient Care STDS; 2004 Dec; 18(12):691-701. PubMed ID: 15659880
[TBL] [Abstract][Full Text] [Related]
2. HIV vaccine trial preparedness among Spanish-speaking Latinos in the US.
Brooks RA; Newman PA; Duan N; Ortiz DJ
AIDS Care; 2007 Jan; 19(1):52-8. PubMed ID: 17129857
[TBL] [Abstract][Full Text] [Related]
3. Posttrial HIV vaccine adoption: concerns, motivators, and intentions among persons at risk for HIV.
Newman PA; Duan N; Rudy ET; Roberts KJ; Swendeman D
J Acquir Immune Defic Syndr; 2004 Nov; 37(3):1393-403. PubMed ID: 15483469
[TBL] [Abstract][Full Text] [Related]
4. Preventive HIV vaccine acceptability and behavioral risk compensation among high-risk men who have sex with men and transgenders in Thailand.
Newman PA; Roungprakhon S; Tepjan S; Yim S
Vaccine; 2010 Jan; 28(4):958-64. PubMed ID: 19925897
[TBL] [Abstract][Full Text] [Related]
5. Preparations for AIDS vaccine trials. Developing brief valid screening instruments for HIV-related sexual risk behavior among gay and bisexual men.
McKirnan DJ; Doetsch J; Vanable P; Buchbinder S; Douglas JM; Judson F
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S285-8. PubMed ID: 7865320
[TBL] [Abstract][Full Text] [Related]
6. Future access to HIV vaccines. Report from a WHO-UNAIDS Consultation, Geneva, 2-3 October 2000.
AIDS; 2001 May; 15(7):W27-44. PubMed ID: 11399975
[TBL] [Abstract][Full Text] [Related]
7. HIV risk and prevention in a post-vaccine context.
Newman PA; Duan N; Rudy ET; Johnston-Roberts K
Vaccine; 2004 May; 22(15-16):1954-63. PubMed ID: 15121308
[TBL] [Abstract][Full Text] [Related]
8. A social vaccine? Social and structural contexts of HIV vaccine acceptability among most-at-risk populations in Thailand.
Newman PA; Roungprakhon S; Tepjan S; Yim S; Walisser R
Glob Public Health; 2012; 7(9):1009-24. PubMed ID: 22780324
[TBL] [Abstract][Full Text] [Related]
9. Participation of homosexual/bisexual men in preventive HIV vaccine trials: baseline attitudes and concerns and predicted behaviors during trials.
Douglas JM; Judson FN; Parks JP; Buchbinder S; McKirnan D
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S257-60. PubMed ID: 7865313
[No Abstract] [Full Text] [Related]
10. Statistical issues in the design of HIV vaccine trials.
Schaper C; Fleming TR; Self SG; Rida WN
Annu Rev Public Health; 1995; 16():1-22. PubMed ID: 7639865
[TBL] [Abstract][Full Text] [Related]
11. Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney, Australia.
Van de Ven P; Mao L; Crawford J; Prestage G; Grulich A; Kaldor J; Kippax S
Int J STD AIDS; 2005 Apr; 16(4):314-7. PubMed ID: 15899086
[TBL] [Abstract][Full Text] [Related]
12. Domestic AIDS vaccine trials: addressing the potential for social harm to the subjects of human experiments.
Leider PA
Calif Law Rev; 2000; 88():1185-232. PubMed ID: 11067733
[TBL] [Abstract][Full Text] [Related]
13. Scaling HIV vaccine attitudes among gay men in Sydney, Australia.
Van De Ven P; Bartholow B; Rawstorne P; Crawford J; Kippax S; Grulich A; Prestage G; Woodhouse M; Murphy D
AIDS Res Hum Retroviruses; 2002 Dec; 18(18):1333-7. PubMed ID: 12487804
[TBL] [Abstract][Full Text] [Related]
14. A small dose of HIV? HIV vaccine mental models and risk communication.
Newman PA; Seiden DS; Roberts KJ; Kakinami L; Duan N
Health Educ Behav; 2009 Apr; 36(2):321-33. PubMed ID: 18032589
[TBL] [Abstract][Full Text] [Related]
15. Community heroes or "high-risk" pariahs? Reasons for declining to enroll in an HIV vaccine trial.
Newman PA; Daley A; Halpenny R; Loutfy M
Vaccine; 2008 Feb; 26(8):1091-7. PubMed ID: 18237829
[TBL] [Abstract][Full Text] [Related]
16. Future HIV vaccine acceptability among young adults in South Africa.
Sayles JN; Macphail CL; Newman PA; Cunningham WE
Health Educ Behav; 2010 Apr; 37(2):193-210. PubMed ID: 19509123
[TBL] [Abstract][Full Text] [Related]
17. Sexual risk behaviour of Canadian participants in the first efficacy trial of a preventive HIV-1 vaccine.
Lampinen TM; Chan K; Remis RS; Merid MF; Rusch M; Vincelette J; Logue K; Popovic V; Alary M; Schechter MT; Hogg RS
CMAJ; 2005 Feb; 172(4):479-83. PubMed ID: 15710939
[TBL] [Abstract][Full Text] [Related]
18. Recruiting London gay men into an HIV vaccine trial: is it feasible?
Sherr L; Bolding G; Elford J
AIDS Care; 2004 Jul; 16(5):565-71. PubMed ID: 15223525
[TBL] [Abstract][Full Text] [Related]
19. The decision to enroll in HIV vaccine efficacy trials: concerns elicited from gay men at increased risk for HIV infection.
MacQueen KM; Buchbinder S; Douglas JM; Judson FN; McKirnan DJ; Bartholow B
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S261-4. PubMed ID: 7865314
[No Abstract] [Full Text] [Related]
20. The urge for an AIDS vaccine: perspectives from a developing country.
Pape JW; Deschamps MM; Verdier RI; Jean S; Desvarieux M; Taverne G; Gelin C; Hyppolite PR; Denize J; Mellon R
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1535-7. PubMed ID: 1467000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
